Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference
Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference
SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano's president and chief executive officer, will present at the RBC Capital Markets 2024 Global Healthcare Conference on May 15, 2024.
聖地亞哥，2024年4月30日（環球新聞專線）——Bionano Genomics, Inc.（納斯達克股票代碼：BNGO）今天宣佈，Bionano總裁兼首席執行官埃裏克·霍姆林博士將於2024年5月15日出席加拿大皇家銀行資本市場2024年全球醫療保健會議。
Conference & Webcast Details
會議和網絡直播詳情
| Date: | May 15, 2024 |
| Time: | 8:00 a.m. to 8:25 a.m. ET |
| Presenter: | Erik Holmlin, PhD, CEO of Bionano |
| Webcast: | Link to Register |
| 日期： | 2024年5月15日 |
| 時間： | 美國東部時間上午 8:00 至上午 8:25 |
| 演示者： | 埃裏克·霍爾姆林博士，Bionano 首席執行官 |
| 網絡直播： | 鏈接到註冊 |
A replay / recording of the session will be available following the conference through the Bionano website at https://ir.bionano.com/ for at least 30 days.
會議結束後，將通過Bionano網站提供會議的重播/錄音，網址爲 https://ir.bionano.com/ 至少 30 天。
About Bionano
關於 Bionano
Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company's mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research, and nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. Through its Lineagen, Inc. d/b/a Bionano Laboratories business, the Company also provides OGM-based testing for certain laboratory developed tests. The Company also offers an industry-leading, platform-agnostic software solution, which integrates next-generation sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view. For more information, visit www.bionano.com and www.bionanolaboratories.com.
Bionano是基因組分析解決方案的提供商，該解決方案可以使研究人員和臨床醫生揭示生物學和醫學中具有挑戰性的問題的答案。該公司的使命是通過OGM解決方案、診斷服務和軟件改變世界看待基因組的方式。該公司爲基礎、轉化和臨床研究的應用提供OGM解決方案，以及使用專有的等位電泳（ITP）技術的核酸提取和純化解決方案。通過其Lineagen, Inc. d/b/a Bionano實驗室業務，該公司還爲某些實驗室開發的測試提供基於OGM的測試。該公司還提供業界領先的、與平台無關的軟件解決方案，該解決方案集成了下一代測序和微陣列數據，旨在在一個綜合視圖中分析、可視化、解釋和報告拷貝數變異、單核苷酸變異以及基因組中沒有雜合性。欲了解更多信息，請訪問 www.bionano.com 和 www.bionanolaboratories.com。
Unless specifically noted otherwise, Bionano's OGM products are for research use only and not for use in diagnostic procedures.
除非另有特別說明，否則Bionano的OGM產品僅用於研究用途，不用於診斷程序。
CONTACTS
聯繫人
Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionano.com
公司聯繫人：
埃裏克·霍爾姆林，首席執行官
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionano.com
Investor Relations:
David Holmes
Gilmartin Group
+1 (858) 888-7625
IR@bionano.com
投資者關係：
大衛霍姆斯
吉爾馬丁集團
+1 (858) 888-7625
IR@bionano.com
Source: Bionano Genomics
來源：Bionano Genomics
譯文內容由第三人軟體翻譯。